Bio-Techne (TECH) Debt to Equity (2016 - 2026)
Bio-Techne has reported Debt to Equity over the past 12 years, most recently at $0.13 for Q4 2025.
- For Q4 2025, Debt to Equity fell 10.42% year-over-year to $0.13; the TTM value through Dec 2025 reached $0.13, down 10.42%, while the annual FY2025 figure was $0.18, 16.95% up from the prior year.
- Debt to Equity for Q4 2025 was $0.13 at Bio-Techne, down from $0.15 in the prior quarter.
- Over five years, Debt to Equity peaked at $0.23 in Q4 2023 and troughed at $0.11 in Q4 2022.
- A 5-year average of $0.17 and a median of $0.16 in 2022 define the central range for Debt to Equity.
- Biggest five-year swings in Debt to Equity: tumbled 56.54% in 2021 and later surged 107.97% in 2023.
- Year by year, Debt to Equity stood at $0.17 in 2021, then crashed by 33.94% to $0.11 in 2022, then surged by 107.97% to $0.23 in 2023, then tumbled by 36.6% to $0.14 in 2024, then decreased by 10.42% to $0.13 in 2025.
- Business Quant data shows Debt to Equity for TECH at $0.13 in Q4 2025, $0.15 in Q3 2025, and $0.18 in Q2 2025.